生物药物治疗后严重喘时与存在症相关的演变和因素
Justine Subocz1, Thomas Stoup1, Jonathan Giovannelli2
1Univ. Lille, CHU Lille, F-59000, Lille, France.
Respiratory medicine
|December 17, 2025
概括
生物治疗显著降低了严重喘患者的存在主义和工作生产力损失. 控制喘已经成为影响现实主义水平及其改善的关键因素.
科学领域:
- 肺部病理学 肺部病理学
- 职业健康 职业健康 职业健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘显著损害了工作生产力,当下主义 (在生病时工作) 是一个鲜为人知的方面.
- 生物疗法对严重喘时的存在感的影响需要进一步研究.
研究的目的:
- 评估在接受生物治疗的严重喘患者中存在感的变化.
- 为了确定与这种患者群体中存在感相关的因素.
主要方法:
- 一项国家,多中心,不受控制的队列研究包括167名严重喘患者在劳动力中活跃.
- 患者在基线和六个月的生物治疗后进行了评估.
- 工作生产力和活动障碍 (WPAI):喘问卷测量了出席,缺勤和工作生产力损失.
主要成果:
- 生物治疗导致了显著减少现场主义 (平均下降14.9%) 和工作生产力损失 (15.4%).
- 没有观察到缺勤率的显著变化.
- 起始时高呈现性与不受控制的喘和高通风症状有关.
结论:
- 尽管研究的局限性,生物药物显示出在减轻严重喘中的存在主义和工作障碍方面的潜力.
- 改善喘控制是降低出席率和更好的工作结果的主要决定因素.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K


